Myocardial injury and protection related to cardiopulmonary bypass

Best Practice and Research: Clinical Anaesthesiology

Volumn 29, Issue 2, 2015, Pages 137-149

  De Hert, Stefan ^a   Moerman, Anneliese ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

cardioprotection; cardiopulmonary bypass; conditioning; heart; ischemia reperfusion injury; myocardium

Indexed keywords

ARTICLE; CARDIOPULMONARY BYPASS; HEART FUNCTION; HEART MUSCLE INJURY; HEART MUSCLE OXYGEN CONSUMPTION; HEART PROTECTION; HEART SURGERY; HUMAN; INFLAMMATION; ISCHEMIC PRECONDITIONING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REPERFUSION INJURY; ADVERSE EFFECTS; ANIMAL; METABOLISM; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; OXYGEN CONSUMPTION; PHYSIOLOGY;

ANIMALS; CARDIOPULMONARY BYPASS; HUMANS; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; OXYGEN CONSUMPTION;

EID: 84947029059     PISSN: 15216896     EISSN: 1532169X     Source Type: Journal    
DOI: 10.1016/j.bpa.2015.03.002     Document Type: Review

References (75)

1. M.B. Forman, D.W. Puett, and R. Virmani Endothelial and myocardial injury during ischemia and reperfusion: pathogenesis and therapeutic implications J Am Coll Cardiol 13 1989 450 459
2. S.G. De Hert Myocardial protection from ischemia and reperfusion injury A. Mebazaa, M. Gheorghiade, F.M. Zannad, Acute heart failure 1st ed. 2008 Springer-Verlag London 70 86
3. C.D. Collard, and S. Gelman Pathophysiology, clinical manifestations, and prevention of ischemia-reperfusion injury Anesthesiology 94 2001 1133 1138
4. M. Zaugg, E. Lucchinetti, M. Uecker, and et al. Anaesthetics and cardiac preconditioning. Part I. Signalling and cytoprotective mechanisms Br J Anaesth 91 2003 551 565
5. H.M. Honda, P. Korge, and J.N. Weiss Mitochondria and ischemia/reperfusion injury Ann N Y Acad Sci 1047 2005 248 258
6. J.G. Laffey, J.F. Boylan, and D.C.H. Cheng The systemic inflammatory response to cardiac surgery Anesthesiology 97 2002 215 252
7. O.J. Warren, A.J. Smith, C. Alexiou, and et al. The inflammatory response to cardiopulmonary bypass: part 1 - mechanisms of pathogenesis J Cardiothorac Vasc Anesth 23 2009 223 231
8. O.J. Warren, A.L. Watret, K.L. de Wit, and et al. The inflammatory response to cardiopulmonary bypass: part 2 - anti-inflammatory therapeutic strategies J Cardiothorac Vasc Anesth 23 2009 384 393
9. C.S.H. Ng, and S. Wan Limiting inflammatory response to cardiopulmonary bypass: pharmaceutical strategies Curr Opin Pharmacol 12 2012 155 159
10. J.G. Augoustides The inflammatory response to cardiac surgery with cardiopulmonary bypass: should steroid prophylaxis be routine? J Cardiothorac Vasc Anesth 26 2012 952 958
11. J.M. Dieleman, A.P. Nierich, P.M. Rosseel, and et al. Intraoperative high-dose dexamethasone for cardiac surgery: a randomized controlled trial JAMA 308 2012 1761 1767
12. D. van Osch, J.M. Dieleman, D. van Dijk, and et al. Dexamethasone for the prevention of postoperative atrial fibrillation Int J Cardiol 182 2015 431 437
13. E.H. Sonnenblick, J. Ross Jr., and E. Braunwald Oxygen consumption of the heart. Newer concepts of its multifactorial determination Am J Cardiol 22 1968 328 336
14. G.D. Buckberg, J.R. Brazier, R.L. Nelson, and et al. Studies of the effects of hypothermia on regional myocardial blood flow and metabolism during cardiopulmonary bypass. I. The adequately perfused beating, fibrillating, and arrested heart J Thorac Cardiovasc Surg 73 1977 87 94
15. A.R. Cordell Milestones in the development of cardioplegia Ann Thorac Surg 60 1995 793 796
16. G.D. Buckberg Update on current techniques on myocardial protection Ann Thorac Surg 60 1995 805 814
17. M.C. Mauney, and I.L. Kron The physiologic basis of warm cardioplegia Ann Thorac Surg 60 1995 819 823
18. J.C. Cleveland Jr., D.R. Meldrum, R.T. Rowland, and et al. Optimal myocardial preservation: cooling, cardioplegia, and conditioning Ann Thorac Surg 61 1996 760 768
19. V. Guru, J. Omura, A.A. Alghamdi, and et al. Is blood superior to crystalloid cardioplegia? A meta-analysis of randomized clinical trials Circulation 114 2006 I331 I338
20. S. Jacob, A. Kallikourdis, F. Sellke, and et al. Is blood cardioplegia superior to crystalloid cardioplegia? Interact Cardiovasc Thorac Surg 7 2008 491 499
21. C.E. Murry, R.B. Jennings, and K.A. Reimer Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium Circulation 74 1986 1124 1136
22. Z.-Q. Zhao, J.S. Corvera, M.E. Halkos, and et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning Am J Physiol Heart Circ Physiol 285 2003 H579 H588
23. Y. Birnbaum, S.L. Hale, and R.A. Kloner Ischemic preconditioning at a distance: reduction of myocardial infarct size by partial reduction of blood supply combined with rapid stimulation of the gastrocnemius muscle in the rabbit Circulation 96 1997 1641 1646
24. G. Andreka, M. Vertesaljai, G. Szantho, and et al. Remote ischaemic postconditioning protects the heart during acute myocardial infarction in pigs Heart 93 2007 749 752
25. ATP channel Annu Rev Physiol 62 2000 79 109
26. D.J. Hausenloy, and D.M. Yellon Survival kinases in ischemic preconditioning and postconditioning Cardiovasc Res 70 2006 240 253
27. D.J. Hausenloy, and D.M. Yellon Reperfusion injury salvage kinase signaling: taking a RISK for cardioprotection Heart Fail Rev 12 2007 217 234
28. D.J. Hausenloy, and D.M. Yellon Preconditioning and postconditioning: united at reperfusion Pharmacol Ther 116 2007 173 191
29. P. Ferdinandy, R. Schulz, and G.F. Baxter Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning Pharmacol Rev 59 2007 418 458
30. D.J. Hausenloy, S.-B. Ong, and D.M. Yellon The mitochondrial permeability transition pore as a target for preconditioning and postconditioning Basic Res Cardiol 104 2009 189 202
31. D.J. Hausenloy, and D.M. Yellon Preconditioning and postconditioning: underlying mechanisms and clinical application Atherosclerosis 204 2009 334 341
32. D.J. Hausenloy, and D.M. Yellon The second window of preconditioning (SWOP): where are we now? Cardiovasc Drug Ther 24 2010 235 254
33. M. Ovize, G.F. Baxter, F. Di Lisa, and et al. Postconditioning and protection from reperfusion injury: where do we stand? Cardiovasc Res 87 2010 406 423
34. S. Lavi, and R. Lavi Conditioning of the heart: from pharmacological interventions to local and remote protection. Possible implications for clinical practice Int J Cardiol 146 2011 311 318
35. R.K. Kharbanda, T.T. Nielsen, and A.N. Redington Translation of remote ischaemic preconditioning into clinical practice Lancet 374 2009 1557 1565
36. C.K. Pac-Soo, H. Mathew, and D. Ma Ischaemic conditioning strategies reduce ischaemia/reperfusion-induced organ injury Br J Anaesth 114 2015 204 216
37. D.M. Yellon, A.M. Alkhulaifi, and W.B. Pugsley Preconditioning the human myocardium Lancet 342 1993 276 277
38. D.P. Jenkins, W.B. Pugsley, and A.M. Alkhulaifi Ischaemic preconditioning reduces troponin T release in patients undergoing coronary artery bypass surgery Heart 77 1997 314 318
39. Z.K. Wu, T. Iivainen, E. Pehkonen, and et al. Ischemic preconditioning suppresses ventricular tachyarrhythmias after myocardial revascularization Circulation 106 2002 3091 3096
40. S. Durdu, M. Sirlak, D. Cetintas, and et al. The efficacies of modified mechanical post conditioning on myocardial protection for patients undergoing coronary artery bypass grafting J Cardiothorac Surg 7 2012 73
41. B. Pouzet, J.B. Lecharny, M. Dehoux, and et al. Is there a place for preconditioning during cardiac operations in humans? Ann Thorac Surg 73 2002 843 848
42. D.J. Hausenloy, P.K. Mwamure, V. Venugopal, and et al. Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomized controlled trial Lancet 370 2007 575 579
43. V. Venugopal, D.J. Hausenloy, A. Ludman, and et al. Remote ischaemic preconditioning reduces myocardial injury in patients undergoing cardiac surgery with cold-blood cardioplegia: a randomized controlled trial Heart 95 2009 1567 1571
44. I.A. Rahman, J.G. Mascaro, R.P. Steeds, and et al. Remote ischemic preconditioning in human coronary artery bypass surgery: from promise to disappointment? Circulation 122 2010 S53 S59
45. D. Brevoord, M.W. Hollmann, S.G. De Hert, and et al. Effect of remote ischemic conditioning on atrial fibrillation and outcome after coronary artery bypass grafting (RICO-trial) BMC Anesthesiol 11 2011 11
46. T. Kaneko, Y. Saito, Y. Hikawa, and et al. Dose-dependent prophylactic effect of nicorandil, an ATP sensitive potassium channel opener, on intra-operative myocardial ischaemia in patients undergoing major abdominal surgery Br J Anaesth 86 2001 332 337
47. N.K. Chinnan, G.D. Puri, and S.K. Thingnam Myocardial protection by nicorandil during open heart surgery under cardiopulmonary bypass Eur J Anaesth 24 2007 26 32
48. C. Piot, P. Croisille, P. Staat, and et al. Effect of cyclosporine on reperfusion injury in acute myocardial infarction N Engl J Med 359 2008 473 481
49. N. Mewton, P. Croisille, G. Gahide, and et al. Effect of cyclosporine on left ventricular remodeling after reperfused myocardial infarction J Am Coll Cardiol 55 2010 1200 1205
50. D.J. Hausenloy, G. Kunst, E. Boston-Griffiths, and et al. The effect of cyclosporine-A on perioperative myocardial injury in adult patients undergoing coronary artery bypass graft surgery: a randomized controlled clinical trial Heart 100 2014 544 549
51. M. Zaugg, E. Lucchinetti, C. Garcia, and et al. Part 2. Clinical implications Br J Anaesth 91 2003 556 576
52. M.W. Bienengraeber, D. Weihrauch, J.R. Kersten, and et al. Cardioprotection by volatile anesthetics Vasc Pharmacol 42 2005 243 252
53. S.G. De Hert, F. Turani, S. Mathur, and D.F. Stowe Cardioprotection with volatile anesthetics: mechanisms and clinical implications Anesth Analg 100 2005 1584 1593
54. P.S. Pagel Postconditioning by volatile anesthetics: salvaging ischemic myocardium at reperfusion by activation of prosurvival signaling J Cardiothorac Vasc Anesth 22 2008 753 765
55. J. Frädorf, S. De Hert, and W. Schlack Anaesthesia and myocardial ischaemia/reperfusion injury Br J Anaesth 103 2009 89 98
56. J. Frädorf, A. Borowski, D. Edel, and et al. Impact of preconditioning protocol on anesthetic-induced cardioprotection in patients having coronary artery bypass surgery J Thorac Cardiovasc Surg 137 2009 1436 1442
57. B. Bein, J. Renner, D. Caliebe, and et al. The effects of interrupted or continuous administration of sevoflurane on preconditioning before cardiopulmonary bypass in coronary artery surgery: comparison with continuous propofol Anaesthesia 63 2008 1046 1055
58. G.S. Murphy, J.W. Szokol, J.H. Marymont, and et al. Opioids and cardioprotection: the impact of morphine and fentanyl on recovery of ventricular function after cardiopulmonary bypass J Cardiothorac Vasc Anesth 20 2006 493 502
59. G.S. Murphy, J.W. Szokol, J.H. Marymont, and et al. The effects of morphine and fentanyl on the inflammatory response to cardiopulmonary bypass in patients undergoing elective coronary artery bypass graft surgery Anesth Analg 104 2007 1334 1342
60. N.D. Nader, C.M. Li, W.Z. Khadra, and et al. Anesthetic myocardial protection with sevoflurane J Cardiothorac Vasc Anesth 18 2004 269 274
61. N.D. Nader, H.L. Karamanoukian, R.L. Reedy, and et al. Inclusion of sevoflurane in cardioplegia reduces neutrophil activity during cardiopulmonary bypass J Cardiothorac Vasc Anesth 20 2006 57 62
62. K.A. Kortekaas, A. van der Baan, L.P.H.J. Aarts, and et al. Cardiospecific sevoflurane treatment quenches inflammation but does not attenuate myocardial cell damage markers: a proof-of-concept study in patients undergoing mitral valve repair Br J Anaesth 112 2014 1005 1014
63. Y. Zuo, X. Cheng, E. Gu, and et al. Effect of aortic root infusion of sufentanil on ischemia-reperfusion injury in patients undergoing mitral valve replacement J Cardiothorac Vasc Anesth 28 2014 1474 1478
64. Z. Xia, Z. Huang, and D.M. Ansley Large-dose propofol during cardiopulmonary bypass decreases biochemical markers of myocardial injury in coronary surgery patients: a comparison with isoflurane Anesth Analg 103 2006 527 532
65. Z.E. Plummer, S. Baos, C.A. Rogers, and et al. The effects of propofol cardioplegia on blood and myocardial biomarkers of stress and injury in patients with isolated coronary artery bypass grafting or aortic valve replacement using cardiopulmonary bypass: protocol for a single-center randomized controlled trial JMIR Res Protoc 3 2014 e35
66. S.G. De Hert, P.J. Van der Linden, S. Cromheecke, and et al. Cardioprotective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its administration Anesthesiology 101 2004 299 310
67. Z. Huang, X. Zhong, M.G. Irwin, and et al. Synergy of isoflurane preconditioning and propofol postconditioning reduces myocardial reperfusion injury in patients Clin Sci 121 2011 57 69
68. S.G. De Hert, P.W. ten Broecke, E. Mertens, and et al. Sevoflurane but not propofol preserves myocardial function in coronary surgery patients Anesthesiology 97 2002 42 49
69. G. Landoni, G.G. Biondi-Zoccai, A. Zangrilla, and et al. Desflurane and sevoflurane in cardiac surgery: a meta-analysis of randomized clinical trials J Cardiothorac Vasc Anesth 21 2007 502 511
70. K. Julier, R. da Silva, C. Garcia, and et al. Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery: a double-blinded, placebo-controlled, multicenter study Anesthesiology 98 2003 1315 1327
71. C. Garcia, K. Julier, L. Bestmann, and et al. Preconditioning with sevoflurane decreases PECAM-1 expression and improves one-year cardiovascular outcome in coronary artery bypass graft surgery Br J Anaesth 94 2005 159 165
72. S. De Hert, D. Vlasselaers, R. Barbé, and et al. A comparison of volatile and non volatile agents for cardioprotection during on-pump coronary surgery Anaesthesia 64 2009 953 960
73. S.G. De Hert Is anaesthetic cardioprotection clinically relevant ? Another futile search for a magic bullet Eur J Anaesth 28 2011 616 617
74. B. Bein Clinical application of the cardioprotective effects of volatile anaesthetics -PRO: get an extra benefit from a proven anaesthetic free of charge Eur J Anaesth 28 2011 620 622
75. N. Van Rompaey, and L. Barvais Clinical application of the cardioprotective effects ofvolatile anaesthetics - CON: TIVA or not TIVA to anaesthetise a cardiac patient? Eur J Anaesth 28 2011 623 627